ArticleSensors (Basel, Switzerland)2022
A Robust End-to-End Deep Learning-Based Approach for Effective and Reliable BTD Using MR Images.
Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 47 citations in OpenAlex.
- Brain Tumor Classification Using Convolutional Neural Network and Bitterling Fish Optimization Algorithm.Diagnostics (Basel, Switzerland) · 2026Article
- Brain tumor classification using optimized ResNet50 with dynamic precision optimization for enhanced speed and diagnostic accuracy.Scientific reports · 2026Article
- Enhanced image registration based brain tumour segmentation using optical particle swarm intelligence technique with Resnet Inceptionv2 HCNN.Scientific reports · 2025Article
- Advanced dynamic ensemble framework with explainability driven insights for precision brain tumor classification across datasets.Scientific reports · 2025Article
- Synergizing advanced algorithm of explainable artificial intelligence with hybrid model for enhanced brain tumor detection in healthcare.Scientific reports · 2025Article
- A multi-layered defense against adversarial attacks in brain tumor classification using ensemble adversarial training and feature squeezing.Scientific reports · 2025Article
- Design of an Optimal Convolutional Neural Network Architecture for MRI Brain Tumor Classification by Exploiting Particle Swarm Optimization.Journal of imaging · 2025Article
- CDCG-UNet: Chaotic Optimization Assisted Brain Tumor Segmentation Based on Dilated Channel Gate Attention U-Net Model.Neuroinformatics · 2025Article
- Advanced Brain Tumor Classification in MR Images Using Transfer Learning and Pre-Trained Deep CNN Models.Cancers · 2025Article
- IV3TM: Inception V3 enabled bidirectional long short-term memory network for brain tumor classification.PloS one · 2025Article
- Efficient brain tumor grade classification using ensemble deep learning models.BMC medical imaging · 2024Article
- Medical image analysis using improved SAM-Med2D: segmentation and classification perspectives.BMC medical imaging · 2024Article
- Advancing multi-categorization and segmentation in brain tumors using novel efficient deep learning approaches.PeerJ. Computer science · 2024Article
- Performance Evaluation of Machine Learning Algorithms for Sarcopenia Diagnosis in Older Adults.Healthcare (Basel, Switzerland) · 2023Article
- A Holistic Approach to Identify and Classify COVID-19 from Chest Radiographs, ECG, and CT-Scan Images Using ShuffleNet Convolutional Neural Network.Diagnostics (Basel, Switzerland) · 2023Article
- An effective approach for plant leaf diseases classification based on a novel DeepPlantNet deep learning model.Frontiers in plant science · 2023Article
- A classifier model for prostate cancer diagnosis using CNNs and transfer learning with multi-parametric MRI.Frontiers in oncology · 2023Article
- TumorDetNet: A unified deep learning model for brain tumor detection and classification.PloS one · 2023Article
- Clinical Decision Support Framework for Segmentation and Classification of Brain Tumor MRIs Using a U-Net and DCNN Cascaded Learning Algorithm.Healthcare (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
Abstract
Detection of a brain tumor in the early stages is critical for clinical practice and survival rate. Brain tumors arise in multiple shapes, sizes, and features with various treatment options. Tumor detection manually is challenging, time-consuming, and prone to error. Magnetic resonance imaging (MRI) scans are mostly used for tumor detection due to their non-invasive properties and also avoid painful biopsy. MRI scanning of one patient's brain generates many 3D images from multiple directions, making the manual detection of tumors very difficult, error-prone, and time-consuming. Therefore, there is a considerable need for autonomous diagnostics tools to detect brain tumors accurately. In this research, we have presented a novel TumorResnet deep learning (DL) model for brain detection, i.e., binary classification. The TumorResNet model employs 20 convolution layers with a leaky ReLU (LReLU) activation function for feature map activation to compute the most distinctive deep features. Finally, three fully connected classification layers are used to classify brain tumors MRI into normal and tumorous. The performance of the proposed TumorResNet architecture is evaluated on a standard Kaggle brain tumor MRI dataset for brain tumor detection (BTD), which contains brain tumor and normal MR images. The proposed model achieved a good accuracy of 99.33% for BTD. These experimental results, including the cross-dataset setting, validate the superiority of the TumorResNet model over the contemporary frameworks. This study offers an automated BTD method that aids in the early diagnosis of brain cancers. This procedure has a substantial impact on improving treatment options and patient survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.